{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:56:33Z","timestamp":1773420993605,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00405-013-2821-5","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T14:43:39Z","timestamp":1384785819000},"page":"1329-1334","source":"Crossref","is-referenced-by-count":18,"title":["Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS"],"prefix":"10.1007","volume":"271","author":[{"given":"Erkan","family":"Vuralkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murad","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Hikmet","family":"Firat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Akaydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sagit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istemihan","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Miser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sad\u0131k","family":"Ardic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"key":"2821_CR1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(94)92088-5","volume":"344","author":"NJ Douglas","year":"1994","unstructured":"Douglas NJ, Polo O (1994) Pathogenesis of sleep apnoea\/hypopnoea syndrome. Lancet 344:653\u2013655. doi: 10.1016\/S0140-6736(94)92088-5","journal-title":"Lancet"},{"key":"2821_CR2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/ajrccm.162.2.9908091","volume":"162","author":"R Schulz","year":"2000","unstructured":"Schulz R, Mahmoudi S, Hattar K et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566\u2013570. doi: 10.1164\/ajrccm.162.2.9908091","journal-title":"Am J Respir Crit Care Med"},{"key":"2821_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","volume":"163","author":"E Shahar","year":"2001","unstructured":"Shahar E, Whitney CW, Redline S et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med 163:19\u201325. doi: 10.1164\/ajrccm.163.1.2001008","journal-title":"Am J Respir Crit Care Med"},{"key":"2821_CR4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1164\/rccm.2105124","volume":"166","author":"Y Peker","year":"2002","unstructured":"Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow up. Am J Respir Crit Care Med 166:159\u2013165. doi: 10.1164\/rccm.2105124","journal-title":"Am J Respir Crit Care Med"},{"key":"2821_CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827\u2013839. doi: 10.1161\/01.RES.0000070112.80711.3D","journal-title":"Circ Res"},{"key":"2821_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/hc0402.102621","volume":"105","author":"TW Carrell","year":"2002","unstructured":"Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A (2002) Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477\u2013482","journal-title":"Circulation"},{"key":"2821_CR7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0735-1097(98)00250-2","volume":"32","author":"H Kai","year":"1998","unstructured":"Kai H, Ikeda H, Yasukawa H et al (1998) Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368\u2013372","journal-title":"J Am Coll Cardiol"},{"key":"2821_CR8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","volume":"107","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Rupprecht HJ, Poirier O et al (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579\u20131585","journal-title":"Circulation"},{"key":"2821_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/carcin\/23.5.769","volume":"23","author":"S Kondo","year":"2002","unstructured":"Kondo S, Kubota S, Shimo T et al (2002) Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769\u2013776. doi: 10.1093\/carcin\/23.5.769","journal-title":"Carcinogenesis"},{"issue":"Pt 1","key":"2821_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj3220317","volume":"322","author":"JR Requena","year":"1997","unstructured":"Requena JR, Fu MX, Ahmed MU et al (1997) Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 322(Pt 1):317\u2013325","journal-title":"Biochem J"},{"key":"2821_CR11","doi-asserted-by":"crossref","first-page":"19661","DOI":"10.1074\/jbc.274.28.19661","volume":"274","author":"DA Slatter","year":"1999","unstructured":"Slatter DA, Paul RG, Murray M, Bailey AJ (1999) Reactions of lipid-derived malondialdehyde with collagen. J Biol Chem 274:19661\u201319669. doi: 10.1074\/jbc.274.28.19661","journal-title":"J Biol Chem"},{"key":"2821_CR12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0167-4943(97)00023-X","volume":"25","author":"G Mehmetcik","year":"1997","unstructured":"Mehmetcik G, Ozdemirler G, Kanbagli O, Toker G, Uysal M (1997) Age-related changes in plasma lipid peroxidation and antioxidant system in humans and rats. Arch Gerontol Geriatr 25:305\u2013310 PII: S0167-4943(97)00023-X","journal-title":"Arch Gerontol Geriatr"},{"key":"2821_CR13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0378-4347(00)00174-2","volume":"742","author":"J Pilz","year":"2000","unstructured":"Pilz J, Meineke I, Gleiter CH (2000) Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr 742:315\u2013325. doi: 10.1016\/S0378-4347(00)00174-2","journal-title":"J Chromatogr"},{"key":"2821_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/smrv.2002.0261","volume":"7","author":"L Lavie","year":"2003","unstructured":"Lavie L (2003) Obstructive sleep apnea syndrome -an oxidative stress disorder. Sleep Med Rev 7:35\u201351. doi: 10.1053\/smrv2002.0261","journal-title":"Sleep Med Rev"},{"key":"2821_CR15","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI119076","volume":"98","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Ramasamy S, Meng XP, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrixmetalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98:2572\u20132579. doi: 10.1172\/JCI119076","journal-title":"J Clin Invest"},{"key":"2821_CR16","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1161\/01.CIR.102.23.2861","volume":"102","author":"D Godin","year":"2000","unstructured":"Godin D, Ivan E, Johnson C, Magid R, Galis ZS (2000) Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessationmodel. Circulation 102:2861\u20132866. doi: 10.1161\/01.CIR.102.23.2861","journal-title":"Circulation"},{"key":"2821_CR17","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000129318.79570.84","volume":"109","author":"J Sundstrom","year":"2004","unstructured":"Sundstrom J, Evans JC, Benjamin EJ et al (2004) Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 109:2850\u20132856. doi: 10.1161\/01.CIR.0000129318.79570.84","journal-title":"Circulation"},{"key":"2821_CR18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/01.CIR.0000089093.75585.98","volume":"108","author":"PE Szmitko","year":"2003","unstructured":"Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S (2003) Biomarkers of vascular disease linking inflammation to endothelial activation: part II. Circulation 108:2041\u20132048. doi: 10.1161\/01.CIR.0000089093.75585.98","journal-title":"Circulation"},{"key":"2821_CR19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.V94.6.2080","volume":"94","author":"AE Kossakowska","year":"1999","unstructured":"Kossakowska AE, Edwards DR, Prusinkiewicz C et al (1999) Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin\u2019s lymphomas. Blood 94:2080\u20132089","journal-title":"Blood"},{"key":"2821_CR20","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1161\/01.CIR.96.10.3555","volume":"96","author":"RD Kenagy","year":"1997","unstructured":"Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW (1997) Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96:3555\u20133560. doi: 10.1161\/01.CIR.96.10.3555","journal-title":"Circulation"},{"key":"2821_CR21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/rccm.200402-193OC","volume":"170","author":"T Tazaki","year":"2004","unstructured":"Tazaki T, Minoguchi K, Yokoe T et al (2004) Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 170:1354\u20131359","journal-title":"Am J Respir Crit Care Med"},{"key":"2821_CR22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00702-005-0316-2","volume":"113","author":"W Jordan","year":"2006","unstructured":"Jordan W, Cohrs S, Degner D et al (2006) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113:239\u2013254. doi: 10.1007\/s00702-005-0316-2","journal-title":"J Neural Transm"},{"issue":"Suppl 6","key":"2821_CR23","first-page":"183","volume":"59","author":"S Cofta","year":"2008","unstructured":"Cofta S, Wysocka E, Piorunek T, Rzymkowska M, Batura-Gabryel H, Torlinski L (2008) Oxidative stres markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 59(Suppl 6):183\u2013190","journal-title":"J Physiol Pharmacol"},{"issue":"Suppl 4","key":"2821_CR24","first-page":"223","volume":"56","author":"M Tafil-Klawe","year":"2005","unstructured":"Tafil-Klawe M, Laudencka A, Klawe JJ, Mi\u015bkowiec I (2005) Does night work favor sleep-related accidents in police officers? J Physiol Pharmacol 56(Suppl 4):223\u2013226","journal-title":"J Physiol Pharmacol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-013-2821-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2821-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T09:02:50Z","timestamp":1596877370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-013-2821-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["2821"],"URL":"https:\/\/doi.org\/10.1007\/s00405-013-2821-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}